These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 30709065)

  • 1. Therapeutic Potential of the Microbiome in the Treatment of Neuropsychiatric Disorders.
    Evrensel A; Önen Ünsalver B; Ceylan ME
    Med Sci (Basel); 2019 Jan; 7(2):. PubMed ID: 30709065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychobiotics.
    Evrensel A; Ünsalver BÖ; Ceylan ME
    Adv Exp Med Biol; 2019; 1192():565-581. PubMed ID: 31705514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fecal Microbiota Transplantation and Its Usage in Neuropsychiatric Disorders.
    Evrensel A; Ceylan ME
    Clin Psychopharmacol Neurosci; 2016 Aug; 14(3):231-7. PubMed ID: 27489376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interventions on Microbiota: Where Do We Stand on a Gut-Brain Link in Autism? A Systematic Review.
    Prosperi M; Santocchi E; Guiducci L; Frinzi J; Morales MA; Tancredi R; Muratori F; Calderoni S
    Nutrients; 2022 Jan; 14(3):. PubMed ID: 35276821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Microbiota-Gut-Brain Axis in Neuropsychiatric Disorders: Pathophysiological Mechanisms and Novel Treatments.
    Kim YK; Shin C
    Curr Neuropharmacol; 2018; 16(5):559-573. PubMed ID: 28925886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic Potential of the Gut Microbiota in the Prevention and Treatment of Sepsis.
    Haak BW; Prescott HC; Wiersinga WJ
    Front Immunol; 2018; 9():2042. PubMed ID: 30250472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fecal microbiota transfer for bowel disorders: efficacy or hype?
    Schmulson M; Bashashati M
    Curr Opin Pharmacol; 2018 Dec; 43():72-80. PubMed ID: 30218939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gut Microbiota and Chronic Constipation: A Review and Update.
    Ohkusa T; Koido S; Nishikawa Y; Sato N
    Front Med (Lausanne); 2019; 6():19. PubMed ID: 30809523
    [No Abstract]   [Full Text] [Related]  

  • 9. [Intestinal microbiota - a vital "organ" with manifold functions].
    Konturek P; Konturek K; Zopf Y; Harsch IA
    MMW Fortschr Med; 2020 Mar; 162(Suppl 4):9-14. PubMed ID: 32189316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microbiota modulation-based therapy for luminal GI disorders: current applications of probiotics and fecal microbiota transplantation.
    Elangovan A; Allegretti JR; Fischer M
    Expert Opin Biol Ther; 2019 Dec; 19(12):1343-1355. PubMed ID: 31570017
    [No Abstract]   [Full Text] [Related]  

  • 11. The role of the microbiome for human health: from basic science to clinical applications.
    Mohajeri MH; Brummer RJM; Rastall RA; Weersma RK; Harmsen HJM; Faas M; Eggersdorfer M
    Eur J Nutr; 2018 May; 57(Suppl 1):1-14. PubMed ID: 29748817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microbiome Disturbances and Autism Spectrum Disorders.
    Rosenfeld CS
    Drug Metab Dispos; 2015 Oct; 43(10):1557-71. PubMed ID: 25852213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fighting Fatty Liver Diseases with Nutritional Interventions, Probiotics, Symbiotics, and Fecal Microbiota Transplantation (FMT).
    Nobili V; Mosca A; Alterio T; Cardile S; Putignani L
    Adv Exp Med Biol; 2019; 1125():85-100. PubMed ID: 30578461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Impact of Chronic Intestinal Inflammation on Brain Disorders: the Microbiota-Gut-Brain Axis.
    Serra D; Almeida LM; Dinis TCP
    Mol Neurobiol; 2019 Oct; 56(10):6941-6951. PubMed ID: 30945157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic interventions for gut dysbiosis and related disorders in the elderly: antibiotics, probiotics or faecal microbiota transplantation?
    Vemuri RC; Gundamaraju R; Shinde T; Eri R
    Benef Microbes; 2017 Apr; 8(2):179-192. PubMed ID: 28008784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alteration of Gut Microbiota in Inflammatory Bowel Disease (IBD): Cause or Consequence? IBD Treatment Targeting the Gut Microbiome.
    Khan I; Ullah N; Zha L; Bai Y; Khan A; Zhao T; Che T; Zhang C
    Pathogens; 2019 Aug; 8(3):. PubMed ID: 31412603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transplanting Fecal Virus-Like Particles Reduces High-Fat Diet-Induced Small Intestinal Bacterial Overgrowth in Mice.
    Lin DM; Koskella B; Ritz NL; Lin D; Carroll-Portillo A; Lin HC
    Front Cell Infect Microbiol; 2019; 9():348. PubMed ID: 31750259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of gut microbiota on neuropsychiatric disorders.
    Cenit MC; Sanz Y; Codoñer-Franch P
    World J Gastroenterol; 2017 Aug; 23(30):5486-5498. PubMed ID: 28852308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gut Microbiota as a Therapeutic Target for Metabolic Disorders.
    Okubo H; Nakatsu Y; Kushiyama A; Yamamotoya T; Matsunaga Y; Inoue MK; Fujishiro M; Sakoda H; Ohno H; Yoneda M; Ono H; Asano T
    Curr Med Chem; 2018; 25(9):984-1001. PubMed ID: 28990516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic modulation of gut microbiota in inflammatory bowel disease: More questions to be answered.
    Qiao YQ; Cai CW; Ran ZH
    J Dig Dis; 2016 Dec; 17(12):800-810. PubMed ID: 27743467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.